Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether he plans to expand the availability of Evusheld as a prophylactic through clinical trials.

The Department’s clinical advisors have recommended a trial of Evusheld is considered to examine a link between in vitro tests and clinical outcomes for current and future variants and evaluate the effectiveness and safety of a dose of 600 milligrams, which was not tested in the randomised controlled trials. The Department will therefore explore options for a clinical trial.